DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹726 Cr | ₹139 Cr | ₹-936 Cr | ₹-70 Cr | ₹1,275 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DR REDDYS LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹726 Cr |
| Mar2024 | ₹139 Cr |
| Mar2023 | ₹-936 Cr |
| Mar2022 | ₹-70 Cr |
| Mar2021 | ₹1,275 Cr |
How is Net Cash Inflow / Outflow of DR REDDYS LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹726 Cr | 423.58 | |
| Mar2024 | ₹139 Cr | Positive | |
| Mar2023 | ₹-936 Cr | Negative | |
| Mar2022 | ₹-70 Cr | Negative | |
| Mar2021 | ₹1,275 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹98,678.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| MANKIND PHARMA | ₹85,330.9 Cr | -0.1% | -4.7% | -13.6% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -4.6% |
-7% |
1.8% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses